Andrew Miller, the chairman of the committee, said that different notified bodies vary in measuring quality and manufacturer often search for those countries that have the least stringent regulations.
"There is an urgent need for more transparency in the regulatory system so that patients and doctors know where their implant is coming from, and crucially whether the product has previously been turned down by other regulatory bodies. I think in the interests of patients we would get a better system in place if the commission speeded up the process to revise current regulations", Miller said.
Source: Medindia
